Kaliumklorid Braun

Potassium Chloride, the active ingredient in Kaliumklorid Braun, is an electrolyte, potassium supplement presented as an intravenous solution for clinical use. It is employed to correct hypokalemia and to provide potassium replacement in patients who require electrolyte management, such as those on diuretics or with renal losses.

GNH USA supplies Kaliumklorid Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide, sourced from the European Union market and meeting stringent quality standards, ensuring consistent potency and safety for patient care.

Kaliumklorid Braun (potassium chloride) is used in electrolyte management to restore normal potassium levels.

- Hypokalemia: restores serum potassium to the normal range, reducing the risk of cardiac arrhythmias. - Potassium replacement therapy: supplies essential potassium ions during peri‑operative care or after prolonged diuretic therapy. - Electrolyte imbalance in renal disease: corrects potassium deficits associated with chronic kidney disease management.

Potassium chloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain or irritation. - Nausea or vomiting. - Mild hyperkalemia.

Serious or Rare Side Effects: - Severe hyperkalemia with cardiac arrhythmias. - Anaphylactic reaction. - Cardiac arrest or ventricular fibrillation.

When using Kaliumklorid Braun, careful monitoring and specific safety measures are required.

- Monitor serum potassium: check levels before and during infusion. - Adjust infusion rate in renal impairment: slower administration to avoid accumulation. - Avoid rapid bolus: limit to recommended infusion speed to reduce cardiac risk. - Use ECG monitoring: observe for arrhythmias during high‑dose therapy. - Contraindicated in existing hyperkalemia: do not administer if serum potassium is elevated. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Potassium chloride can interact with several medicines, altering potassium balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors or ARBs: can potentiate hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium rise. - Trimethoprim‑sulfamethoxazole: may cause additive potassium elevation.

Moderate Interactions (Monitor Closely): - Digoxin: heightened risk of digitalis toxicity with high potassium. - NSAIDs: may reduce renal potassium excretion. - Insulin or beta‑agonists: opposite effect on potassium shift, requiring careful monitoring.